Literature DB >> 6861206

Protection of mice against influenza virus infection: enhancement of nonspecific cellular responses by Corynebacterium parvum.

N K Mak, E Schiltknecht, G L Ada.   

Abstract

Groups of C57BL/6J, BALB/c, BALB/c, nu+/nu+ mice, inoculated intranasally with Corynebacterium parvum (350 micrograms/mouse) were protected from death by an otherwise lethal dose of influenza virus, A/WSN (H1N1) inoculated 3 days later. The lungs of C. parvum-treated, virus-infected C57BL/6J, BALB/c, or BALB/c nu+/nu+ mice contained significantly less infectious virus than did controls, and this reduction was apparent as soon as 24 hr after virus inoculation. The maximum protective effect correlated with increased lung interferon levels. C. parvum treatment caused an increase in the lung cell number which was in part due to a large increase (ca. 10-fold) in macrophage content, and the natural killer cell activity was also enhanced, though not as markedly as occurred 3 days after infection. Most (greater than 85%) of the resident macrophages in normal lungs were susceptible to infection by virus (as indicated by hemadsorption), whereas most of those recovered from the lungs of C. parvum-treated mice resisted infection. Despite the increase in macrophage content, the level of specific immune responses to infection, such as cytotoxic T-cell activity, DTH reaction, and antihemagglutinin antibody, remained unchanged by C. parvum treatment so that the major if not only effect of this treatment was on the level of the less-specific components of the immune system.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6861206     DOI: 10.1016/0008-8749(83)90286-1

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  6 in total

1.  Encephalomyocarditis (EMC) virus-induced diabetes mellitus prevented by Corynebacterium parvum in mice.

Authors:  E Kounoue; S Nagafuchi; M Nakamura; S Nakano; T Koga; M Nakayama; M Mituyama; Y Niho; R Takaki
Journal:  Experientia       Date:  1987-04-15

2.  Enhancement of bronchoalveolar cell recovery and stimulation of alveolar macrophage chemiluminescence and resistance to influenza virus after treatment with RU 41821 aerosol.

Authors:  A Rudent; F Michel; C Labarre; A M Quero; R Zalisz; P Smets
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

3.  Augmented production of granulocyte-macrophage colony-stimulating factor and alpha/beta interferon in mice inoculated with heat-killed Corynebacterium liquefaciens.

Authors:  T Yoshida; T Hotta; K Shimokata; M Ichihara; K Isobe; I Nakashima
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

4.  COVID-19 vaccine and boosted immunity: Nothing ad interim to do?

Authors:  Luca Roncati; Maria Vadalà; Veronica Corazzari; Beniamino Palmieri
Journal:  Vaccine       Date:  2020-10-09       Impact factor: 3.641

5.  Age-Related Changes in the Nasopharyngeal Microbiome Are Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Symptoms Among Children, Adolescents, and Young Adults.

Authors:  Jillian H Hurst; Alexander W McCumber; Jhoanna N Aquino; Javier Rodriguez; Sarah M Heston; Debra J Lugo; Alexandre T Rotta; Nicholas A Turner; Trevor S Pfeiffer; Thaddeus C Gurley; M Anthony Moody; Thomas N Denny; John F Rawls; James S Clark; Christopher W Woods; Matthew S Kelly
Journal:  Clin Infect Dis       Date:  2022-08-24       Impact factor: 20.999

Review 6.  The long-standing history of Corynebacterium parvum, immunity, and viruses.

Authors:  Beniamino Palmieri; Maria Vadalà; Luca Roncati; Andrea Garelli; Francesco Scandone; Moreno Bondi; Claudio Cermelli
Journal:  J Med Virol       Date:  2020-06-29       Impact factor: 20.693

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.